MedTrace Logo

A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas

NCT01598116 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2021-12-14

No results posted yet for this study

Summary

Current treatment options for hemangiomas, such as propranolol, steroids and interferon, all have the potential for significantly harmful side effects. The purpose of this study is to identify potential biomarkers that can be used to design clinical trials and accelerate the delivery of new treatment alternatives to children with hemangiomas.

Conditions

  • Hemangioma

Interventions

PROCEDURE

Urine collection and ultrasonography

Bagged urine collection and ultrasound at each visit

PROCEDURE

Urine collection

Bagged urine collection

Sponsors & Collaborators

  • Nationwide Children's Hospital

    collaborator OTHER

  • Gayle Gordillo

    lead OTHER

Principal Investigators

  • Gayle M Gordillo, MD · Ohio State University

Eligibility

Min Age
4 Weeks
Max Age
5 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-12-12
Primary Completion
2015-12-15
Completion
2017-01-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01598116 on ClinicalTrials.gov